Tian Xu Selected Research

atrophin-1

10/2009	C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice.
5/2006	Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA.
1/2002	Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tian Xu Research Topics

Disease

48	Ischemic Stroke 02/2022 - 01/2013
41	Neoplasms (Cancer) 01/2022 - 02/2002
21	Stroke (Strokes) 02/2022 - 01/2013
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
14	Inflammation (Inflammations) 11/2022 - 09/2013
11	Hypertension (High Blood Pressure) 12/2021 - 01/2014
8	Thrombosis (Thrombus) 03/2021 - 09/2012
7	Obesity 11/2018 - 01/2016
6	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 08/2013
5	Body Weight (Weight, Body) 01/2022 - 01/2016
5	Myocardial Infarction 01/2021 - 01/2013
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
4	Heart Failure 01/2022 - 01/2018
4	Diabetes Mellitus 03/2021 - 08/2017
4	Hyperplasia 03/2021 - 11/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2020 - 01/2002
4	Death (Near-Death Experience) 11/2018 - 01/2013
4	Unstable Angina 11/2018 - 06/2012
3	Non-alcoholic Fatty Liver Disease 12/2021 - 01/2021
3	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2014
3	Carcinogenesis 07/2020 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 05/2019
3	Hypoxia (Hypoxemia) 01/2018 - 02/2002
3	Coronary Disease (Coronary Heart Disease) 08/2017 - 01/2013
3	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 10/2009 - 01/2002
2	Brain Ischemia (Cerebral Ischemia) 02/2022 - 11/2019
2	Dehydration (Water Stress) 01/2022 - 02/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 07/2021
2	Infections 10/2021 - 12/2017
2	Stomach Neoplasms (Stomach Cancer) 07/2021 - 11/2020
2	Triple Negative Breast Neoplasms 07/2021 - 01/2018
2	Reperfusion Injury 01/2021 - 11/2019

Drug/Important Bio-Agent (IBA)

30	Antihypertensive Agents (Antihypertensives)IBA 02/2022 - 02/2014
20	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
13	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2002
12	C-Reactive ProteinIBA 01/2021 - 01/2014
11	LipidsIBA 10/2021 - 01/2014
6	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2017
5	EnzymesIBA 02/2022 - 09/2013
5	Biological ProductsIBA 02/2022 - 01/2021
5	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2013
5	Uric Acid (Urate)IBA 01/2021 - 11/2016
5	oxidized low density lipoproteinIBA 01/2021 - 01/2014
5	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 12/2003
5	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 02/2020 - 01/2016
5	Interleukin-6 (Interleukin 6)IBA 12/2016 - 09/2013
4	Phosphotransferases (Kinase)IBA 06/2022 - 01/2014
4	baicalinIBA 02/2022 - 01/2018
4	Retinaldehyde (Retinal)IBA 01/2022 - 12/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2021 - 04/2014
4	HomocysteineIBA 03/2021 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 03/2016
4	hydroxide ionIBA 10/2017 - 01/2016
4	Triglycerides (Triacylglycerol)IBA 09/2017 - 01/2014
3	InflammasomesIBA 02/2022 - 12/2018
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022 - 08/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
3	AntibodiesIBA 01/2022 - 11/2016
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2014
3	QingkailingIBA 01/2021 - 11/2019
3	LDL CholesterolIBA 01/2021 - 01/2014
3	NLR ProteinsIBA 07/2020 - 11/2019
3	AntioxidantsIBA 10/2019 - 02/2014
3	ORALIT (ORS)IBA 01/2019 - 01/2014
3	Long Noncoding RNAIBA 01/2019 - 01/2018
3	HDL CholesterolIBA 01/2018 - 01/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 03/2009
3	polyglutamineIBA 10/2009 - 01/2002
3	atrophin-1IBA 10/2009 - 01/2002
2	ChemokinesIBA 01/2022 - 01/2020
2	Competitive Endogenous RNAIBA 01/2022 - 01/2022
2	Circular RNAIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Hydroxyl RadicalIBA 01/2022 - 02/2014
2	VaccinesIBA 12/2021 - 10/2021
2	25-hydroxyvitamin DIBA 10/2021 - 08/2017
2	CholesterolIBA 10/2021 - 12/2016
2	Netrin-1IBA 10/2021 - 01/2019
2	AntigensIBA 10/2021 - 01/2016
2	MTOR InhibitorsIBA 07/2021 - 08/2020
2	CytokinesIBA 01/2021 - 09/2008
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 05/2020
2	Cystatin CIBA 01/2021 - 01/2018
2	Thyroid HormonesIBA 01/2021 - 07/2020
2	CreatinineIBA 11/2020 - 01/2018
2	AcidsIBA 09/2020 - 03/2017
2	FlavonoidsIBA 07/2020 - 01/2018
2	Estrogens (Estrogen)FDA Link 07/2020 - 01/2020

Therapy/Procedure

19	Therapeutics 01/2022 - 02/2007
11	Stents 03/2021 - 11/2011
5	Percutaneous Coronary Intervention 07/2021 - 08/2020
5	Drug-Eluting Stents 03/2021 - 08/2013
2	Intravenous Injections 12/2021 - 09/2012
2	Immunotherapy 12/2021 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 11/2020 - 12/2014